Lux Capital is NYC’s deep-tech standard bearer, managing ~$4B+ AUM and backing science-heavy startups across biotech, quantum, space, defense, and AI.

Lux Capital’s investment philosophy

• Frontier over fashion: Science-first, fashion-agnostic.
• Long duration: 10+ year hold patterns accepted.
• Counter-conventional: Lux routinely backs unconventional theses other firms pass on.
• Writer partners: Josh Wolfe’s and Peter Hebert’s public communication sets thesis direction.

Notable Lux investments

• Anduril — defense tech giant.
• Desktop Metal — additive manufacturing.
• Auris Health — surgical robotics (acquired by JNJ for $3.4B).
• Kallyope — gut-brain biology.
• Saildrone — autonomous ocean vehicles.
• Applied Intuition — autonomy development software.
• Latch — smart buildings (public then delisted).
• Planet Labs — satellite imagery (public).
• Clearpath / OTTO Motors — robotics.
• Recursion Pharmaceuticals — AI drug discovery (public).

Lux’s 2026 thesis areas

1. Defense tech — aligned with Anduril thesis and broader dual-use investment surge.
2. AI drug design — extension of Recursion, Kallyope, and biotech bets.
3. Quantum and compute — hardware-software hybrid bets.
4. Space and dual-use aerospace.
5. Bio x AI convergence — foundation models for biology.

What makes Lux unusual for NYC

• Most NYC firms lean SaaS, fintech, or media.
• Lux carries the city’s strongest deep-tech bench, filling a gap that would otherwise mean losing deep-science founders to Bay Area firms.
• Supports broader NYC ecosystem credibility in hard tech.

Practical takeaway

• Founders: Lux is a top choice for frontier-science startups that NYC generalists would reject.
• Investors: Lux portfolio is a leading indicator of sectors approaching inflection.
• LPs: Deep-tech exposure via Lux is a credible way to access the category from NYC.

Sources

1. Lux Capital: https://www.luxcapital.com/
2. Ellenox NYC VC rankings: https://www.ellenox.com/post/new-york-city-venture-capital-firms